Deprecated: preg_replace(): The /e modifier is deprecated, use preg_replace_callback instead in /home/dgjigroup/www/www/inc/parsefile.php on line 7
Dragon Jade International
Location: Dragon Jade International Limited » Press Releases » Dragon Jade International Announces New Treatment for Diabetes

Press Releases

    WHY INVEST IN DRAGON JADE (OTCBB: DGJI)?

  • It becomes abundantly clear that traditional Chinese medicines (TCM) is going to be the next modality and prescribed TCM formulas will be viewed as powerful therapeutic cures. Dragon Jade pioneering endeavors in promoting better access and broader use of TCM will definitely be paid off and return of investments should be remarkable.

  • Dragon Jade in-depth understanding of how to carry out biomedical experimentation, clinical traits, systematic reviews and sampled surveys will surely help its selected traditional Chinese medicines partner companies to meet the western scientific disciplines of medicines or healthcare products.

  • Dragon Jade has extensive know- how techniques to implement and comply with the prescribed codes of practices and relevant laws and ordinances. These merits will definitely attract generous funds and revenues in the near future for there are far too many TCM companies are eager to seek assistance to help them deal with the tough FDA regulatory regime.

  • read more....

    Dragon Jade International Announces New Treatment for Diabetes

    Hong Kong, September 24, 2014 -- Dragon Jade International Limited (OTCQB:DGJI) (the “Company”), has been acquiring several long established and proven Chinese herbal medicinal products from several long standing Chinese medicine practitioners in China, Hong Kong regions, Taiwan and the USA.  The Company is pleased to announce today that it has recently accredited and accepted another Chinese herbal formula that has clinically been proven to treat diabetes.  Specifically, the new product has successfully lowered the AC-glucose level and HbA1C of diabetes patients.  Consumption of the herbal medicine has demonstrated significant health improvements in patients with Diabetes Mellitus.  Diabetes Mellitus is an autoimmune disease that permanently destroys beta cells in the pancreas, meaning that the body can no longer produce insulin, a hormone that enables people to get energy from food.  Lack of insulin production by the pancreas makes diabetes a particularly difficult medical condition to treat.  Scientists believe that both genetic factors and environmental triggers are involved in its cause.  Its onset has nothing to do with diet or lifestyle.  
    Diabetes Mellitus is a serious problem in most of developed and developing countries.  Three hundred and forty seven million people worldwide suffer from diabetes, in 2010 an estimated 3.4 million people died from consequences of fasting high blood sugar.  The World Health Organization projects the diabetes growth rates for 2000-2030 for the key geographic areas are: US (102%), Europe (43%), Asia Pacific (130%) and Africa/Middle East (162%).  In 2012, the total sales of worldwide diabetes medicine were nearly 35 billion US dollars.  Standard and Poor's estimated that the total sales would be more than 58 billion US dollars in 2018. 
    The Company intends to manufacture and distribute the herbal diabetes medicine in tablet form.  It is expected that this naturopathic product will significantly benefit diabetes patients all over the world.  It will be another important addition to the Company’s ever-growing product line of natural healing products. 
    Dr. Yat Man, Lai, C.E.O. of Dragon Jade International Limited said, "Developing Chinese Medicine for Diabetic Mellitus has provided us with extremely favorable access to diabetes market which we have deemed as a key element of our overall strategy for growth.  There are many other components to our strategic aims, but this product sets the stage for our immediate development program and can greatly aid in positioning our company at the forefront of dietary supplement sector." 
     
    About Dragon Jade 
    Dragon Jade International Limited and its subsidiaries ("the Group") focused on identifying, developing and marketing the next generation of herbal and natural products that improve people's lives. The Group is positioned to leverage proven resources that allow us to assess, enhance and realize the commercial potential of herbal and biotechnological discoveries. The Group strives to develop and offer to the market the broadest selection of cost-effective healthy living products, which shall deliver substantial returns to investors.  More information on Dragon Jade, visit the Company's website: http://www.dgjigroup.com. 
     
    Safe Harbor Statement 
    This release includes forward-looking statements. These forward-looking statements generally can be identified by phrases such as DGJI or its management "believes," "expects," "anticipates," "foresees," "forecasts," "estimates" or other words or phrases of similar import. Similarly, statements herein that describe the Company's business strategy, outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in forward-looking statements. 
     
     
    Company Contact: 
    Dr. Yat Man, Lai 
    CEO 
    Phone: 852-3588-1780 
    Email: info@dgjigroup.com